Skip to main content
. 2017 May 9;19(3):435–446. doi: 10.1007/s10198-017-0894-6

Table 2.

Overall COI from the perspective of the society, and costs paid by the counties and the Social Insurance Agency, for MS patients

Overall societal COI Of which paid by county councils and the Social Insurance Agency (i.e., transfers)
SEK (%) SEK (% of total*)
Prescription drug use 583,441,517 (15) 560,027,154 (96)**
Outpatient specialized healthcare use 140,758,388 (4) 133,977,488 (95)**
Inpatient healthcare use 271,472,848 (7) 269,125,488 (99)**
Direct costs 986,544,512 (25) N/A
 Sick leave*** 328,809,660 (8) 137,240,200 (42)****
 Disability pension 2,634,726,838 (67) 799,137,300 (30)****
Indirect costs 2,963,536,506 (75) N/A
COI 3,950,081,018 (100) N/A

The exchange rate is approximately SEK 10 to 1 euro

COI cost-of-illness, MS multiple sclerosis, N/A not applicable, SEK Swedish krona

* Proportion of the total cost for each cost category, compared to the overall COI

** Direct costs not accounted for are the patients’ copayments for prescription drugs and healthcare

*** Calculated based on all sickness benefits, i.e., sickness benefit, preventive sickness benefit, work injury benefit, and rehabilitation compensation

**** The transfer costs are not part of the indirect costs (which indicate the lost production to the employers) but an estimate of the payments made by the society/third part payer, in this case the Social Insurance Agency, to cover wages unpaid by employers due to sickness among their employees